iShares Neuroscience and HeaIBRNETF
13F holders, Q4 2025 (December 31)3holders −1
1new positions
2sold out
$32.32avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, down 1 from Q3 2025. 1 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($2.8M), Cwm, LLC ($5K) and UBS Group AG ($3K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 2 | $21K |
All 13F filers, Q3 2025 → Q4 2025: 92 shares bought and 7,788 shares sold, net −7,696 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| BlackRock, Inc. | 0.00% | Reduce -7.5% | 87,000 | $2.8M |
| Cwm, LLC | 0.00% | No change | 163 | $5K |
| UBS Group AG | 0.00% | New | 92 | $3K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.